Check point inhibitors in peri-operative non small cell lung cancer strategy

J. Mazieres (Toulouse, France)

Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Number: 8
Disease area: Thoracic oncology

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Mazieres (Toulouse, France). Check point inhibitors in peri-operative non small cell lung cancer strategy. ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: